Summary of Classification and Labelling
Notified classification and labelling
General Information
629-899-3 |
N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide |
871700-17-3 |
Notified classification and labelling according to CLP criteria
Skin Sens. 1 |
H317
|
H317
|
|
GHS08 Dgr
|
|
|
|
|
1 |
|
View details
|
Repr. 2 |
H361
(unborn child)
|
H361
(unborn child)
|
STOT RE 1 |
H372
(heart, liver, k...)
(oral)
|
H372
(heart, liver, k...)
|
STOT RE 1 |
H372
(other:heart, li...)
(oral)
|
H372
(heart, liver, k...)
|
Repr. 1B |
H360D
|
H360D
|
|
GHS08 Dgr
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(liver)
(oral)
|
H373
|
Number of Aggregated Notifications: 2